Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supreme Court Hears 'Machine-Or-Transformation' Test Argument For Patents

This article was originally published in The Gray Sheet

Executive Summary

The Supreme Court on Nov. 9 heard arguments for a case that has been watched closely by test makers, who fear that many diagnostics claims will not be patent eligible if a federal appeals court decision is upheld

You may also be interested in...



Supreme Court Gives Some Relief, But Leaves Open Questions For Dx Patents

Diagnostics and biotech firms praised a June 28 Supreme Court opinion for allowing judges some flexibility in ruling on the patent-eligibility of "process" claims, but patent attorneys warn that many issues remain unsettled

Supreme Court Gives Some Relief, But Leaves Open Questions For Dx Patents

Diagnostics and biotech firms praised a June 28 Supreme Court opinion for allowing judges some flexibility in ruling on the patent-eligibility of "process" claims, but patent attorneys warn that many issues remain unsettled

Patent Suits Trigger Molecular Diagnostics Business Uncertainty

Investment in new molecular diagnostics biomarkers, particularly genetic markers, is suffering due to substantial patent law uncertainties, according to test developers at last week's Biotechnology Industry Organization conference in Chicago

Related Content

Topics

UsernamePublicRestriction

Register

MT028180

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel